Table 1

Sialic acid levels in BAL and sera samples of patients with malignant lung diseases (mg/dl).

Patient No.
Age
BAL Fluid
Serum
Diagnosis
Tumor Localization
Tumor Stage

1
55
3.75
64.25
Epidermoid carcinoma
Central
Stage IIB
2
50
1.87
88.60
Epidermoid carcinoma
Central
Stage IIIA
3
64
5.97
73.69
Epidermoid carcinoma
Central
Stage IIIA
4
68
11.09
143.96
Epidermoid carcinoma
Peripheral
Stage IIIB
5
60
7.39
83.93
Small cell carcinoma
Central
Stage IV
6
55
7.52
101.74
Epidermoid carcinoma
Central
Stage IIB
7
72
7.78
134.70
Small cell carcinoma
Central
Stage IV
8
59
8.8
46.07
Adenocarcinoma
Peripheral
Stage IIIB
9
61
10.4
73.82
Epidermoid carcinoma
Central
Stage IB
10
45
2.64
86.26
Adenocarcinoma
Peripheral
Stage IIB
11
59
11.6
103.24
Epidermoid carcinoma
Central
Stage IIIA
12
66
4.4
92.14
Epidermoid carcinoma
Peripheral
Stage IIB
13
62
20
66.61
Epidermoid carcinoma
Central
Stage IB
14
48
16.4
103.24
Epidermoid carcinoma
Central
Stage IIIA
15
51
9.2
82.71
Small cell carcinoma
Central
Stage IV
16
50
11.6
27
Epidermoid carcinoma
Central
Stage IIIA
17
70
4.4
87.98
Epidermoid carcinoma
Peripheral
Stage IIB
18
48
17.9
91.86
Adenocarcinoma
Peripheral
Stage IIIA
19
75
9.2
65.77
Epidermoid carcinoma
Central
Stage IIIB
20
65
28.8
42.35
Large cell carcinoma
Central
Stage IIIA
21
68
15.9
61.61
Large cell Carcinoma
Central
Stage IIIB

Isitmangil et al. BMC Pulmonary Medicine 2001 1:4   doi:10.1186/1471-2466-1-4